What is Genelux Corporation Common Stock (GNLX) stock price today?

Genelux Corporation Common Stock (GNLX) currently trades at $2.67 per share. The stock has a market capitalization of $114.70M and a P/E ratio of —x.

Is GNLX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Genelux Corporation Common Stock has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Genelux Corporation Common Stock's revenue and earnings?

Genelux Corporation Common Stock has trailing twelve-month (TTM) revenue of $8000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.86.

GNLX

Genelux Corporation Common Stock

NASDAQ: GNLX · HEALTHCARE · BIOTECHNOLOGY

$2.67

+6.80% today

Updated 2026-04-30

Market cap

$114.70M

P/E ratio

—

P/S ratio

14,337.86x

EPS (TTM)

$-0.86

Dividend yield

—

52W range

$2 – $9

Volume

0.2M

Market cap

$114.70M

P/E ratio

—

P/S ratio

14,337.86x

EPS (TTM)

$-0.86

Dividend yield

—

52W range

$2 – $9

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$17.50

+555.43%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-6.63M

- Revenue declining -95.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$11.07M	$170000.00	$8000.00	$8000.00	$8000.00
Net income	$-5.21M	$-28.30M	$-29.87M	$-32.15M	$-9.25M
EPS	—	—	—	—	$-0.86
Free cash flow	$-3.62M	$-21.30M	$-21.61M	$-26.37M	$-6.63M
Profit margin	-47.05%	-16,645.29%	-373,362.50%	-401,812.50%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GNLX	$114.70M	16	2.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Genelux Corporation Common Stock trades at $2.67. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $8000.00.

Frequently asked questions

What is Genelux Corporation Common Stock's stock price?

Genelux Corporation Common Stock (GNLX) trades at $2.67.

Is Genelux Corporation Common Stock overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Genelux Corporation Common Stock (GNLX)?

The analyst target price is $17.50, representing +555.4% upside from the current price of $2.67.

What is Genelux Corporation Common Stock's revenue?

TTM revenue is $8000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio14,337.86x

ROE-170.00%

Beta0.46

50D MA$2.64

200D MA$3.82

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GNLX vs LLY →GNLX vs JNJ →GNLX vs ABBV →Stock screener →